Lumexa Imaging Holdings Inc Receivables Turnover Ratio (LMRI), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Lumexa Imaging Holdings Inc   (LMRI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Lumexa Imaging Holdings Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Lumexa Imaging Holdings Inc 's ability to collect accounts receivable sequentially worsen to 18.88, indicating more challenging environment then in the second quarter 2026, but still, it is a far cry from any concerns. Lumexa Imaging Holdings Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 19 days, from 17 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector Lumexa Imaging Holdings Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Lumexa Imaging Holdings Inc Selling?


What is Receivable Turnover Ratio?





LMRI Receivables Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change 8.18 % 7.82 % - - -
Receivable Turnover Ratio (TTM) 18.88 21.76 25.65 158.89 -
LMRI's Total Ranking # # # # #
Accounts Receivable average collection period days 19 17 14 2 -
Seq. Receivable Change 5.14 % -77.17 % 626.72 % - -
Seq. Revenue Change 2.96 % 4.6 % -2.47 % 3 % 2.61 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 






Financial Statements
Lumexa Imaging Holdings Inc 's Accounts Receivable $ 33 Millions Visit LMRI's Balance sheet
Lumexa Imaging Holdings Inc 's Sales TTM $ 1,048 Millions Visit LMRI's Income Statement
Sources of LMRI's Revenues Visit LMRI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LMRI's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LMRI's Growth Rates LMRI's Roa LMRI's Inventory Turnover Ratio LMRI's Dividend Comparisons
LMRI's Profitability Ratios LMRI's Roi LMRI's Asset Turnover Ratio LMRI's Dividend Growth
LMRI's Valuation Ratios LMRI's Roe LMRI's Financial Strength Ratios LMRI's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Lifevantage Corp  72.32 $ 171.248  Millions$ 2.368  Millions
Nurix Therapeutics Inc   70.19 $ 701.936  Millions$ 10.000  Millions
Humacyte Inc   64.89 $ 32.703  Millions$ 0.504  Millions
Kiniksa Pharmaceuticals International Plc  40.65 $ 945.963  Millions$ 23.272  Millions
Innovage Holding Corp   34.59 $ 1,018.359  Millions$ 29.443  Millions
Fortrea Holdings Inc   29.58 $ 2,666.700  Millions$ 90.150  Millions
Sonida Senior Living Inc   27.65 $ 638.130  Millions$ 23.076  Millions
Wave Life Sciences Ltd   24.65 $ 87.296  Millions$ 3.541  Millions
Lenz Therapeutics Inc   24.39 $ 12.359  Millions$ 0.507  Millions
Arvinas Inc   20.06 $ 275.300  Millions$ 13.725  Millions
U S Physical Therapy Inc  18.16 $ 837.629  Millions$ 46.137  Millions
Alpha Pro Tech Ltd   17.54 $ 64.940  Millions$ 3.702  Millions
Biogen Inc   15.19 $ 10,297.300  Millions$ 677.900  Millions
Lifestance Health Group Inc   14.89 $ 1,676.889  Millions$ 112.631  Millions
Amneal Pharmaceuticals Inc   14.24 $ 3,196.184  Millions$ 224.488  Millions
Corcept Therapeutics Inc  13.44 $ 963.647  Millions$ 71.710  Millions
Precipio inc   13.38 $ 27.762  Millions$ 2.075  Millions
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Biodesix Inc   11.45 $ 105.212  Millions$ 9.192  Millions
Gossamer Bio Inc   11.37 $ 78.423  Millions$ 6.896  Millions
Icu Medical Inc  11.32 $ 2,183.556  Millions$ 192.845  Millions
Mannkind Corporation  10.97 $ 413.370  Millions$ 37.686  Millions
Lensar Inc   10.64 $ 60.079  Millions$ 5.645  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Voyager Therapeutics Inc   9.84 $ 25.108  Millions$ 2.551  Millions
Myomo Inc   9.66 $ 47.775  Millions$ 4.947  Millions
Encompass Health Corporation  9.41 $ 6,338.100  Millions$ 673.625  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions

Date modified: 2026-11-13T08:45:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.